Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis

NCT00566618 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Bone Metastases

Interventions

DRUG: Dasatinib
DRUG: Zoledronic Acid

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]